Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Cell Culture Media, Sera, and Reagents Market Poised to Touch US $7.1 Billion by 2023: Transparency Market Research


News provided by

Transparency Market Research

21 Sep, 2015, 13:30 GMT

Share this article

Share toX

Share this article

Share toX

ALBANY, New York, September 21, 2015 /PRNewswire/ --

According to a new market report published by Transparency Market Research 'Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023',  the global cell culture media, sera, and reagents market was valued at US $3.7 billion in 2014 and is estimated to reach US $7.1 billion by 2023 at a CAGR of 7.6% from 2015 to 2023.

The cell culture market has been extensively analyzed on the basis of media, sera, and reagents. The cell culture media segment has been sub-segmented into chemically defined, classical, lysogeny broth, protein-free, serum-free, and specialty media. The cell culture sera segment has been sub-segmented into fetal bovine serum, newborn calf and adult bovine serum, and others. The cell culture reagents segment has been sub-segmented into albumin, amino acids, attachment factors, growth factors and cytokines, protease inhibitors, and others. The albumin segment has been further studied for human serum albumin, bovine serum albumin, and recombinant serum albumin. The growth factors and cytokines segment has been studied for insulin-like growth factors, interleukins and interferon, tumor necrosis factors, and other growth factors and cytokines. The other reagents segment has been sub-segmented into porcine trypsin, recombinant trypsin, thrombin, and miscellaneous reagents.

Browse Market Research Report with ToC & Free Analysis: http://www.transparencymarketresearch.com/cell-culture-media-sera-reagents-market.html

Cell culture media has been identified as the largest segment of the cell culture media, sera, and reagents market in 2014. Cell culture industry experts are of the opinion that end-users seek high quality media that provide both reproducible results as well as robust yields. The adoption of chemically defined media has been slow yet steady for both media manufacturers and bio processors. Demand for media has been shifting from serum-based to serum-sparing, serum-free animal derived, and chemically-defined media. Improvements in cell productivity and cell culture have led to the adoption of smaller processes that employ single use equipment. This has increased demand for ready-to-use liquid media and media powders.

Get Sample Report Copy: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6598

Sera provides wide range of macromolecules, trace elements, carrier proteins, spreading factors, hormones, low molecular weight nutrients, and other growth factors. Serum is commonly used as a supplement in cell culture media. Serum in general is an imprecise component of cell culture media, as a number of serum-free media formulations are being developed and introduced in the market. In addition, media without serum or animal derived components are considered ideal for the study of the role and function of small molecule drug candidates.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/cell-culture-media-sera-reagents-market.htm

Cell culture reagents are chemicals that are used to synthesize or detect another substance under study in the culture. Most commonly used reagents are cell dissociation reagents, extracellular attachment matrices, cell freezing media, and cell washing solutions, growth factors, amino acids and other related products.

Browse Other Reports of Transparency Market Research: 

  • Dyslipidemia Drugs Market: http://www.transparencymarketresearch.com/dyslipidemia-market.html
  • Healthcare Business Intelligence Market: http://www.transparencymarketresearch.com/healthcare-business-intelligence.html
  • Noscapine Base Market: http://www.transparencymarketresearch.com/noscapine-base-market.html

The Global Cell Culture Media, Sera, and Reagents Market has been segmented as given below: 

Global Cell Culture Media Market Revenue, by Type 

  • Chemically defined
  • Classical
  • Lysogeny broth (LB)
  • Protein-free
  • Serum-free
  • Specialty

Global Cell Culture Sera Market Revenue, by Type 

  • Fetal Bovine
  • Newborn Calf and Adult Bovine Sera
  • Others

Global Cell Culture Reagents Market Revenue, by Type 

Albumin 

  • Human Serum Albumin (HSA)
  • Bovine Serum Albumin (BSA)
  • Recombinant Serum Albumin (RSA)

Amino Acids 

Attachment Factors 

Growth Factors & Cytokines 

  • Insulin-like Growth Factors (IGF)
  • HumanKine Growth Factors and Cytokine
  • Tumor Necrosis Factor (TNF)
  • Others

Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others) 

Others 

  • Porcine Trypsin
  • Recombinant Trypsin
  • Thrombin
  • Miscellaneous Reagents

Global Cell Culture Media, Sera, and Reagents Market Revenue, by Geography 

North America 

  • U.S.
  • Canada

Europe 

  • U.K.
  • Germany
  • Rest of Europe

Asia Pacific 

  • China
  • India
  • Japan
  • Korea
  • Rest of Asia Pacific

Latin America (LATAM) 

  • Brazil
  • Mexico
  • Rest of Latin America

Rest of the World (RoW) 

  • Israel
  • Russia
  • Rest of RoW

Browse All Other Medical Market Research Reports: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us:

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Media Contact: 

Transparency Market Research

Mr. Nachiket Ghumare
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.